Negligent Drug Design Claims May Increase In Pa.

Law360, New York (February 4, 2014, 4:02 PM EST) -- Recently, The Pennsylvania Supreme Court ruled under its state law that pharmaceutical companies such as Pfizer Inc. are prone to being sued for a "lack of due care." The Supreme Court ruling derived from the initial 2006 Wyeth lawsuit filed (Patsy Lance, et al. v. Wyeth, et al., Nos. 17 EAP 2011 and 18 EAP 2011, Pa. Sup.; 2014 Pa. LEXIS 205), at Philadelphia Common Pleas Court. Wyeth Pharmaceuticals Inc. was acquired by Pfizer (NYSE: PFE) for $68 billion in 2009. The proposed ruling aims to stop the marketing of harmful drugs deemed unreasonable....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!